Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
6
6 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- Modified recombinant human C-type natriuretic peptideBMN 111Phase 32 trials
BioMarin · Achondroplasia
- BMN 333Phase 31 trial
BioMarin · Achondroplasia
- KK8398Phase 31 trial
Kyowa Kirin Co., Ltd. · Achondroplasia
- DabogratinibTYRA-300Phase 24 trials
Tyra Biosciences, Inc · FGFR3 Gene Mutation, FGFR3 Gene Alteration, Achondroplasia
- ABSK061Phase 22 trials
Abbisko Therapeutics Co, Ltd · HER2-Gastric/Gastroesophageal Junction Cancer, Urothelial Carcinoma, Non-Small Cell Lung Cancer
- Combination of NavepegritidePhase 21 trial
Ascendis Pharma Growth Disorders A/S · Achondroplasia
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.